Exocrine and Endocrine Modulation in Common Gastric Carcinoma-Reference-Cited by-同舟云学术

Exocrine and Endocrine Modulation in Common Gastric Carcinoma

Published:2012-05 Issue:5 Volume:137 Page:712-721
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Canzonieri Vincenzo,Colarossi Cristina,Del Col Laura,Perin Tiziana,Talamini Renato,Sigon Roberto,Cannizzaro Renato,Aiello Eleonora,Buonadonna Angela,Italia Fabrizio,Massi Daniela,Carbone Antonino,Memeo Lorenzo

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/137/5/712/18134194/ajcpath137-0712.pdf

Reference32 articles.

1. Ferlay J Shin HR Bray F GLOBOCAN 2008. v1.2. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. http://globocan.iarc.fr. Accessed July 1, 2011.

2. Shibata A Parsonnet J . Stomach cancer. In: Schottenfeld D Fraumeni JF Jr , eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:707–720.

3. Advances in the treatment of patients with gastric adenocarcinoma

4. Role of Helicobacter pylori in Gastric Carcinogenesis: The Origin of Gastric Cancers and Heterotopic Proliferative Glands in Mongolian Gerbils

5. Neuroendocrine differentiation in gastric adenocarcinomas: an immunohistochemical study;Blumenfeld;Arch Pathol Lab Med,1996

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Modality Treatment for Locally Advanced Gastric Cancer: Current Evidences and New Perspectives;Current Clinical Pathology;2019

2. Diagnostic, Prognostic, Predictive and Therapeutic Tissue Biomarkers in Gastric Cancer;Current Clinical Pathology;2019

3. Pathological Diagnosis and Classification of Gastric Epithelial Tumours;Current Clinical Pathology;2019

4. Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases;Journal of Gastric Cancer;2019

5. Cancer Targeted Therapy Strategy: The Pathologist’s Perspectives;Current Cancer Drug Targets;2018-05-22